Davide Valentini

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Peter Bergman, Ola Blennow, Lotta Hansson et al. · EBioMedicine · 2021 · 219 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis

Simani Gaseitsiwe, Davide Valentini, Shahnaz Mahdavifar et al. · PLoS ONE · 2008 · 72 citations · Full text

Normalization of oligonucleotide arrays based on the least-variant set of genes

Stefano Calza, Davide Valentini, Yudi Pawitan · BMC Bioinformatics · 2008 · 55 citations · Full text

Peptide Microarray-Based Identification of <i>Mycobacterium tuberculosis</i> Epitope Binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401

Simani Gaseitsiwe, Davide Valentini, Shahnaz Mahdavifar et al. · Clinical and Vaccine Immunology · 2009 · 46 citations · Full text

Peptide Microarray-based Identification, Adaptive Immune System, Immunology +18

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals

Katie Healy, Elisa Pin, Puran Chen et al. · Med · 2022 · 40 citations · Full text